According to authorities in China, a drug used in Japan to treat new strains of influenza has appeared to be effective in coronavirus patients.
An official at China’s science and technology ministry, said favipiravir, developed by a subsidiary of Fujifilm, had produced encouraging outcomes in clinical trials in Wuhan and Shenzhen involving 340 patients.
Patients who were given the medicine turned negative for the virus after an average of four days after becoming positive, compared with an average of 11 days for those who were not treated with the drug.
In addition, X-rays confirmed improvements in lung condition in about 91% of the patients who were treated with favipiravir, compared to 62% or those without the drug.
Five suspects have been arrested after an armed robbery this afternoon in Lyon
Read More
In Paris, left-wing and far-right MPs have joined forces to pass a new measure against tax optimisation by multinational corporations, during the firs...
Read More
A ceremony took place in Nice this morning to mark the fifth anniversary of the attack at the Notre-Dame Basilica ...
Read More
Income from fixed speed cameras in France fell by €76 million in 2024, dropping to €889 million from €965 million in 2023. The fall comes after many c...
Read More
There’s been a large increase in unemployment in France. Just over 3.2 million people were completely unemployed in the third quarter...
Read More
